Literature DB >> 32513665

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19.

Meagan L Adamsick1, Ronak G Gandhi1, Monique R Bidell1, Ramy H Elshaboury1, Roby P Bhattacharyya2, Arthur Y Kim2, Sagar Nigwekar3, Eugene P Rhee3, Meghan E Sise4.   

Abstract

Entities:  

Keywords:  COVID-19; acute renal failure; antiviral; end-stage renal disease

Mesh：

Substances：

Year:  2020        PMID： 32513665      PMCID： PMC7351006          DOI： 10.1681/ASN.2020050589

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  13 in total

1.  Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy.

Authors:  Abhijat Kitchlu; Joshua Shapiro; Eitan Amir; Amit X Garg; S Joseph Kim; Ron Wald; Ziv Harel
Journal:  JAMA       Date:  2018-06-19       Impact factor: 56.272

2.  A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

Authors:  Sabue Mulangu; Lori E Dodd; Richard T Davey; Olivier Tshiani Mbaya; Michael Proschan; Daniel Mukadi; Mariano Lusakibanza Manzo; Didier Nzolo; Antoine Tshomba Oloma; Augustin Ibanda; Rosine Ali; Sinaré Coulibaly; Adam C Levine; Rebecca Grais; Janet Diaz; H Clifford Lane; Jean-Jacques Muyembe-Tamfum; Billy Sivahera; Modet Camara; Richard Kojan; Robert Walker; Bonnie Dighero-Kemp; Huyen Cao; Philippe Mukumbayi; Placide Mbala-Kingebeni; Steve Ahuka; Sarah Albert; Tyler Bonnett; Ian Crozier; Michael Duvenhage; Calvin Proffitt; Marc Teitelbaum; Thomas Moench; Jamila Aboulhab; Kevin Barrett; Kelly Cahill; Katherine Cone; Risa Eckes; Lisa Hensley; Betsey Herpin; Elizabeth Higgs; Julie Ledgerwood; Jerome Pierson; Mary Smolskis; Ydrissa Sow; John Tierney; Sumathi Sivapalasingam; Wendy Holman; Nikki Gettinger; David Vallée; Jacqueline Nordwall
Journal:  N Engl J Med       Date:  2019-11-27       Impact factor: 91.245

3.  Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.

Authors:  Verena Hafner; David Czock; Jürgen Burhenne; Klaus-Dieter Riedel; Jürgen Bommer; Gerd Mikus; Christoph Machleidt; Thomas Weinreich; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

4.  Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

Authors:  Leal C Herlitz; Sumit Mohan; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Kidney Int       Date:  2010-09-01       Impact factor: 10.612

5.  Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

Authors:  Timothy P Sheahan; Amy C Sims; Rachel L Graham; Vineet D Menachery; Lisa E Gralinski; James B Case; Sarah R Leist; Krzysztof Pyrc; Joy Y Feng; Iva Trantcheva; Roy Bannister; Yeojin Park; Darius Babusis; Michael O Clarke; Richard L Mackman; Jamie E Spahn; Christopher A Palmiotti; Dustin Siegel; Adrian S Ray; Tomas Cihlar; Robert Jordan; Mark R Denison; Ralph S Baric
Journal:  Sci Transl Med       Date:  2017-06-28       Impact factor: 17.956

6.  Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.

Authors:  Marc A von Mach; Jürgen Burhenne; Ludwig S Weilemann
Journal:  BMC Clin Pharmacol       Date:  2006-09-18

7.  Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.

Authors:  Tyree H Kiser; Douglas N Fish; Christina L Aquilante; Joseph E Rower; Michael F Wempe; Robert MacLaren; Isaac Teitelbaum
Journal:  Crit Care       Date:  2015-02-03       Impact factor: 9.097

8.  Compassionate Use of Remdesivir for Patients with Severe Covid-19.

Authors:  Jonathan Grein; Norio Ohmagari; Daniel Shin; George Diaz; Erika Asperges; Antonella Castagna; Torsten Feldt; Gary Green; Margaret L Green; François-Xavier Lescure; Emanuele Nicastri; Rentaro Oda; Kikuo Yo; Eugenia Quiros-Roldan; Alex Studemeister; John Redinski; Seema Ahmed; Jorge Bernett; Daniel Chelliah; Danny Chen; Shingo Chihara; Stuart H Cohen; Jennifer Cunningham; Antonella D'Arminio Monforte; Saad Ismail; Hideaki Kato; Giuseppe Lapadula; Erwan L'Her; Toshitaka Maeno; Sumit Majumder; Marco Massari; Marta Mora-Rillo; Yoshikazu Mutoh; Duc Nguyen; Ewa Verweij; Alexander Zoufaly; Anu O Osinusi; Adam DeZure; Yang Zhao; Lijie Zhong; Anand Chokkalingam; Emon Elboudwarej; Laura Telep; Leighann Timbs; Ilana Henne; Scott Sellers; Huyen Cao; Susanna K Tan; Lucinda Winterbourne; Polly Desai; Robertino Mera; Anuj Gaggar; Robert P Myers; Diana M Brainard; Richard Childs; Timothy Flanigan
Journal:  N Engl J Med       Date:  2020-04-10       Impact factor: 91.245

9.  Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Yeming Wang; Dingyu Zhang; Guanhua Du; Ronghui Du; Jianping Zhao; Yang Jin; Shouzhi Fu; Ling Gao; Zhenshun Cheng; Qiaofa Lu; Yi Hu; Guangwei Luo; Ke Wang; Yang Lu; Huadong Li; Shuzhen Wang; Shunan Ruan; Chengqing Yang; Chunlin Mei; Yi Wang; Dan Ding; Feng Wu; Xin Tang; Xianzhi Ye; Yingchun Ye; Bing Liu; Jie Yang; Wen Yin; Aili Wang; Guohui Fan; Fei Zhou; Zhibo Liu; Xiaoying Gu; Jiuyang Xu; Lianhan Shang; Yi Zhang; Lianjun Cao; Tingting Guo; Yan Wan; Hong Qin; Yushen Jiang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Bin Cao; Chen Wang
Journal:  Lancet       Date:  2020-04-29       Impact factor: 79.321

10.  Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.

Authors:  Travis K Warren; Robert Jordan; Michael K Lo; Adrian S Ray; Richard L Mackman; Veronica Soloveva; Dustin Siegel; Michel Perron; Roy Bannister; Hon C Hui; Nate Larson; Robert Strickley; Jay Wells; Kelly S Stuthman; Sean A Van Tongeren; Nicole L Garza; Ginger Donnelly; Amy C Shurtleff; Cary J Retterer; Dima Gharaibeh; Rouzbeh Zamani; Tara Kenny; Brett P Eaton; Elizabeth Grimes; Lisa S Welch; Laura Gomba; Catherine L Wilhelmsen; Donald K Nichols; Jonathan E Nuss; Elyse R Nagle; Jeffrey R Kugelman; Gustavo Palacios; Edward Doerffler; Sean Neville; Ernest Carra; Michael O Clarke; Lijun Zhang; Willard Lew; Bruce Ross; Queenie Wang; Kwon Chun; Lydia Wolfe; Darius Babusis; Yeojin Park; Kirsten M Stray; Iva Trancheva; Joy Y Feng; Ona Barauskas; Yili Xu; Pamela Wong; Molly R Braun; Mike Flint; Laura K McMullan; Shan-Shan Chen; Rachel Fearns; Swami Swaminathan; Douglas L Mayers; Christina F Spiropoulou; William A Lee; Stuart T Nichol; Tomas Cihlar; Sina Bavari
Journal:  Nature       Date:  2016-03-02       Impact factor: 49.962
View more
  48 in total

1.  A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.

Authors:  Rituvanthikaa Seethapathy; Sophia Zhao; Joshua D Long; Ian A Strohbehn; Meghan E Sise
Journal:  Kidney360       Date:  2021-12-03

Review 2.  New Insights Into Drug Repurposing for COVID-19 Using Deep Learning.

Authors:  Chun Yen Lee; Yi-Ping Phoebe Chen
Journal:  IEEE Trans Neural Netw Learn Syst       Date:  2021-10-27       Impact factor: 10.451

Review 3.  Kidney implications of SARS-CoV2 infection in children.

Authors:  Erica C Bjornstad; Michael E Seifert; Keia Sanderson; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2021-08-28       Impact factor: 3.651

4.  Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019.

Authors:  Jeremy Yuen-Chun Teoh; Terry Cheuk-Fung Yip; Grace Chung-Yan Lui; Vincent Wai-Sun Wong; Viola Chi-Ying Chow; Tracy Hang-Yee Ho; Timothy Chun-Man Li; Yee-Kit Tse; Peter Ka-Fung Chiu; Chi-Fai Ng; David Shu-Cheong Hui; Henry Lik-Yuen Chan; Cheuk-Chun Szeto; Grace Lai-Hung Wong
Journal:  J Am Soc Nephrol       Date:  2021-01-22       Impact factor: 10.121

5.  Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis.

Authors:  Massimo Tempestilli; Giulia Valeria Stazi; Gaetano Maffongelli; Maria Cristina Marini; Tommaso Ascoli Bartoli; Giuseppe Ippolito; Emanuele Nicastri; Luisa Marchioni; Chiara Agrati
Journal:  Eur J Clin Pharmacol       Date:  2021-05-12       Impact factor: 3.064

6.  Feasibility and safety of remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation.

Authors:  Hari S Meshram; Vivek B Kute; Himanshu Patel; Subho Banerjee; Vijay Navadiya; Sudeep Desai; Syed J Rizvi; Vineet Mishra; Sanshriti Chauhan
Journal:  Transpl Infect Dis       Date:  2021-05-18

7.  Liver and kidney function in patients with Covid-19 treated with remdesivir.

Authors:  Sylvia A van Laar; Mark G J de Boer; Kim B Gombert-Handoko; Henk-Jan Guchelaar; Juliette Zwaveling
Journal:  Br J Clin Pharmacol       Date:  2021-05-04       Impact factor: 3.716

Review 8.  COVID-19 and AKI: Where Do We Stand?

Authors:  Paul M Palevsky
Journal:  J Am Soc Nephrol       Date:  2021-02-26       Impact factor: 10.121

9.  Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys.

Authors:  Lin Xu; Bo Tan; Di Huang; Meijie Yuan; Tingting Li; Ming Wu; Chaoyang Ye
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

10.  Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy.

Authors:  Julius J Schmidt; Stefanie M Bode-Böger; Jens Martens-Lobenhoffer; Marius M Hoeper; Jan T Kielstein
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-23       Impact factor: 10.614
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.